Everand Logo

Welcome to Everand!

  • STAT

    Opinion: A government database is supposed to help people seeking treatment for opioid addiction. It often doesn’t

    by Lila Flavin and J. Wesley Boyd Jan 09, 2020 3 minutes
    A man holds his bottle of buprenorphine.

    Recovering from opioid addiction isn’t easy. The pull of the drug is strong. Asking for help to kick an addiction can be difficult for many people, in part because of the stigma associated with addiction.

    One of the most effective means of beating an opioid addiction is to use a prescription medication, buprenorphine, which binds to the same receptor as opioids and reduces the craving for them.

    But finding a clinician who prescribes buprenorphine . Some people ask their primary care physician for a reference. Others ask friends or acquaintances who they’d recommend. Many others, though, consult the , a database curated by the federal government’s Substance Abuse and Mental Health Services Administration that lists clinicians who can prescribe buprenorphine.

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Plans For Generic Wegovy, Cough Syrup Warnings, And More
    Biocon is developing a generic version of Novo Nordisk's Wegovy and is prepared to conduct a clinical trial next year if needed.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
    Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
    MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.

    Related Books & Audiobooks